[go: up one dir, main page]

MXPA04000517A - Medicamentos profilacticos de ascitis para aves de corral. - Google Patents

Medicamentos profilacticos de ascitis para aves de corral.

Info

Publication number
MXPA04000517A
MXPA04000517A MXPA04000517A MXPA04000517A MXPA04000517A MX PA04000517 A MXPA04000517 A MX PA04000517A MX PA04000517 A MXPA04000517 A MX PA04000517A MX PA04000517 A MXPA04000517 A MX PA04000517A MX PA04000517 A MXPA04000517 A MX PA04000517A
Authority
MX
Mexico
Prior art keywords
preventives
ascites
poultry
surfactant
containing coenzyme
Prior art date
Application number
MXPA04000517A
Other languages
English (en)
Inventor
Tsuyoshi Minemura
Original Assignee
Idemitsu Kosan Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idemitsu Kosan Co filed Critical Idemitsu Kosan Co
Publication of MXPA04000517A publication Critical patent/MXPA04000517A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se propone proporcionar medicamentos profilacticos para ascitis que contienen coenzima Q, la cual puede ejercer un efecto suficiente para evitar la ascitis, incluso en el caso de administrarse en una dosis pequena dentro de un periodo de tiempo corto, y medicamentos profilacticos de ascitis que pueden ser administrados eficazmente a aves de corral por un metodo conveniente. Particularmente, medicamentos profilacticos para aves de corral que contienen coenzima Q y un surfactante, en donde el contenido del surfactante esta en el intervalo de 0.5 a 80 partes en peso, basado en los medicamentos profilacticos enteros.
MXPA04000517A 2001-07-17 2002-07-17 Medicamentos profilacticos de ascitis para aves de corral. MXPA04000517A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001216545 2001-07-17
PCT/JP2002/007251 WO2003007928A1 (fr) 2001-07-17 2002-07-17 Medicaments prophylactiques contre l'ascite pour la volaille

Publications (1)

Publication Number Publication Date
MXPA04000517A true MXPA04000517A (es) 2006-03-03

Family

ID=19051012

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04000517A MXPA04000517A (es) 2001-07-17 2002-07-17 Medicamentos profilacticos de ascitis para aves de corral.

Country Status (5)

Country Link
US (1) US7033588B2 (es)
JP (1) JP4503286B2 (es)
CN (1) CN100335045C (es)
MX (1) MXPA04000517A (es)
WO (1) WO2003007928A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100525753C (zh) * 2005-11-15 2009-08-12 董英杰 辅酶q10亚微乳注射液及制备方法
BRPI0621518B1 (pt) * 2006-03-21 2022-05-10 Taminco Método para o tratamento não terapêutico das aves domésticas, ração para aves domésticas, e, uso de um composto de glicina e/ou de um sal do mesmo
JPWO2008156108A1 (ja) * 2007-06-21 2010-08-26 株式会社カネカ 機能性家畜生産品およびその製造方法
US20170231926A1 (en) * 2014-08-13 2017-08-17 Nisshin Pharma Inc. Livestock production method and livestock-growth promoting method
JP2017101002A (ja) * 2015-12-04 2017-06-08 イーエヌ大塚製薬株式会社 腹水貯留改善用栄養組成物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5218811A (en) * 1975-08-01 1977-02-12 Eisai Co Ltd Preparation of aqueous solution of fat- soluble substances
JPS5942649B2 (ja) * 1976-02-14 1984-10-16 エーザイ株式会社 重症筋無力症治療剤
JPS5581813A (en) * 1978-12-16 1980-06-20 Nisshin Flour Milling Co Ltd Composition containing coenzyme q10 and its perparation
JPS62123113A (ja) * 1985-11-22 1987-06-04 Green Cross Corp:The ユビデカレノン含有脂肪乳剤
CN86100582A (zh) * 1986-05-21 1987-12-02 泰州生物化学制药厂 一种使辅酶q10注射液保持澄明的方法
JP2512310B2 (ja) * 1987-06-24 1996-07-03 エーザイ株式会社 被覆脂肪乳剤
JPH0532974A (ja) * 1991-07-26 1993-02-09 Sumitomo Metal Ind Ltd コークス炉における乾留制御方法
IT1256386B (it) * 1992-11-13 1995-12-04 Luigi Boltri Composizioni farmaceutiche comprendenti un farmaco,una sostanza polimerica reticolata,un olio ed un agente tensioattivo
JPH07123928A (ja) * 1993-11-09 1995-05-16 Ajinomoto Co Inc 家禽疾病予防剤及び家禽用飼料
JPH09187229A (ja) * 1996-01-10 1997-07-22 Idemitsu Material Kk 家禽用飼料組成物
JP2002223708A (ja) * 1997-05-14 2002-08-13 Idemitsu Material Kk ブロイラー用飼料組成物およびブロイラー飼育方法
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US20020102301A1 (en) * 2000-01-13 2002-08-01 Joseph Schwarz Pharmaceutical solid self-emulsifying composition for sustained delivery of biologically active compounds and the process for preparation thereof
US6441050B1 (en) * 2000-08-29 2002-08-27 Raj K. Chopra Palatable oral coenzyme Q liquid

Also Published As

Publication number Publication date
JP4503286B2 (ja) 2010-07-14
CN100335045C (zh) 2007-09-05
US7033588B2 (en) 2006-04-25
JPWO2003007928A1 (ja) 2004-11-04
US20040156836A1 (en) 2004-08-12
WO2003007928A1 (fr) 2003-01-30
CN1555257A (zh) 2004-12-15

Similar Documents

Publication Publication Date Title
PT973413E (pt) Formulacoes nutricionais que contem lacto-n-neotetraose
AP2002002552A0 (en) Pharmaceutical compositions providing enhanced drug concentrations.
GB2368283A (en) Cyclobenzaprine for treating generalized anxiety disorder and compositions thereof
MXPA05009196A (es) Estuche generador de espuma que contiene un despachador generador de espuma y una composicion con un alto nivel de surfactante.
AU4451101A (en) Method and compositions for preventing hormone induced adverse effects
AU2330202A (en) Treatment of statin side effects
PL375900A1 (en) Dosage forms containing a proton pump inhibitor, a nsaid, and a buffer
MY135711A (en) Osmotic delivery system with early zero order push power engine
MXPA04010392A (es) Composiciones de cromo y metodos para utilizar las mismas para inhibir resistencia a insulina inducida por droga.
PT1283038E (pt) Composições normalizadoras do ritmo circadiano
SI1297013T1 (sl) Uporaba TACI kot protitumorskega sredstva
EP1158977A4 (en) METHOD AND COMPOSITION RELATING TO THE ADMINISTRATION OF A CYCLO-OXYGENASE-2 INHIBITOR
SI1603580T1 (sl) Sestava za dajanje Ĺľeleza za zdravljenje sindroma nemirnih nog
GB0228723D0 (en) Treatment of pain
WO2002004409A3 (en) Tetrahydrobenzothiazole analogues as neuroprotective agents
MXPA05003732A (es) Metodos y composiciones para proporcionar glutamina.
EA200200502A1 (ru) Способ введения ингибитора фосфодиэстеразы 4
MXPA04000517A (es) Medicamentos profilacticos de ascitis para aves de corral.
AU2003292006A1 (en) 3,5,3'-triiodothyronine sulfate as thyromimetic agent and pharmaceutical formulations thereof
PL365253A1 (en) Food supplement with a slimming effect
NZ528164A (en) Use of flumazenil to produce a medicament for the treatment of cocaine dependency
MY123537A (en) Method of stabilizing n-oxyl compounds in vinyl compounds
GB2387101A (en) Compositions containing creatine and creatinine
BR0009949A (pt) Método para reduzir unidades de formação de colÈnia de bactérias em levedura, e, levedura
MXPA02007296A (es) Composicion farmaceutica que comprende portadores para productos basados en vitamina 3, papaina e hialuronidasa.

Legal Events

Date Code Title Description
FG Grant or registration